SCHEMBL6578833

SCHEMBL6578833

COc1ccc(N)c(Cl)c1COc1ccc2nc(C)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 5/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
CASP6 P55212 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE10A Q9Y233 8/20 0.39
TEC P42680 1/20 0.39
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
PPARG P37231 1/20 0.36
KLKB1 P03952 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580627 0.87 NCF1 (0.41) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6936592 0.87 KDM4E (0.42) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6580770 0.86 NCF1 (0.40) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6578390 0.84 NQO1 (0.41) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6581525 0.83 NCF1 (0.39) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6580686 0.82 S1PR4 (0.44) LMNAPOLBALDH1A1CYP1A2
SCHEMBL6578780 0.82 NCF1 (0.40) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6581464 0.77 KDM4E (0.44) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6578484 0.76 NCF1 (0.39) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6578830 0.76 BDKRB2 (0.60) KDM4ELMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed